Covered recipient · General Payments record
SABEEN YAQUB
Allopathic & Osteopathic Physicians Internal Medicine Rheumatology
General Payments · PY2018–2024
$2,941.02
- Reported across 99 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,029.52 | 34 |
| Education | $19.25 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $356.70 | 18 |
| W. L. Gore & Associates, Inc. | $207.73 | 1 |
| Acerta Pharma LLC | $162.33 | 5 |
| Cook Medical LLC | $86.05 | 1 |
| UCB, Inc. | $77.02 | 3 |
| Amgen Inc. | $49.28 | 2 |
| Sandoz Inc. | $32.67 | 1 |
| GlaxoSmithKline, LLC. | $21.63 | 1 |
| SOBI, INC | $19.25 | 1 |
| E.R. Squibb & Sons, L.L.C. | $19.03 | 1 |
| GENZYME CORPORATION | $17.08 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $12.16 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106372140 | CMS |
| ABBVIE INC. | $7.37 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106372142 | CMS |
| ABBVIE INC. | $19.43 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106372144 | CMS |
| ABBVIE INC. | $10.43 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106372146 | CMS |
| ABBVIE INC. | $9.82 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106372148 | CMS |
| ABBVIE INC. | $125.00 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106372150 | CMS |
| ABBVIE INC. | $26.97 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106372152 | CMS |
| ABBVIE INC. | $7.89 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106372154 | CMS |
| ABBVIE INC. | $9.98 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106372156 | CMS |
| ABBVIE INC. | $21.08 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106372158 | CMS |
| ABBVIE INC. | $8.41 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106372160 | CMS |
| ABBVIE INC. | $10.35 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106372162 | CMS |
| ABBVIE INC. | $29.19 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106372164 | CMS |
| ABBVIE INC. | $9.57 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106372166 | CMS |
| ABBVIE INC. | $10.24 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106372168 | CMS |
| ABBVIE INC. | $8.95 | 11/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106372170 | CMS |
| ABBVIE INC. | $12.12 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106372172 | CMS |
| ABBVIE INC. | $17.74 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106372174 | CMS |
| Amgen Inc. | $27.16 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116218061 | CMS |
| Amgen Inc. | $22.12 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116218065 | CMS |
| AstraZeneca Pharmaceuticals LP | $89.73 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105713054 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.83 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104678069 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.71 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105712906 | CMS |
| AstraZeneca Pharmaceuticals LP | $20.84 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105701056 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.22 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105493973 | CMS |
| Cook Medical LLC | $86.05 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118329142 | CMS |
| E.R. Squibb & Sons, L.L.C. | $19.03 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101257581 | CMS |
| GENZYME CORPORATION | $17.08 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139795054 | CMS |
| GlaxoSmithKline, LLC. | $21.63 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116260600 | CMS |
| Sandoz Inc. | $32.67 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089371746 | CMS |
| SOBI, INC | $19.25 | 08/19/2024 | Education | Undisputed | 01/23/2026 | 1141411150 | CMS |
| UCB, Inc. | $27.10 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143055457 | CMS |
| UCB, Inc. | $15.83 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143055459 | CMS |
| UCB, Inc. | $34.09 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143055461 | CMS |
| W. L. Gore & Associates, Inc. | $207.73 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148069365 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.